| 1 | Dupilumab | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [8] 51 51, 97, 98, 160, 162, 222, 300, 306 💬
|
| 2 | Fluticasone | [1] Fluticasone Fluticasone | [1] Fluticasone
Fluticasone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [4] 98 98, 228, 299, 306 💬
|
| 3 | FLUTICASONE PROPIONATE | [2] Fluticasone Fluticasone, Fluticasone propionate | [2] Fluticasone propionate
Fluticasone propionate
,
Fluticasone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 98 98, 228, 306 💬
|
| 4 | Formoterol | [1] Formoterol Formoterol | [2] Formoterol fumarate
Formoterol fumarate
,
Formoterol
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 85 85, 228, 299, 306 💬
|